Files and links (1)
Accepted (AM)Open Access (License Unspecified), Open
Journal article
Electronic Nicotine Delivery Systems (ENDS) Use and Pregnancy I: ENDS Use Behavior During Pregnancy
Current addiction reports, v 8(3), pp 347-365
01 Sep 2021
PMID: 34513567
Featured in Collection : UN Sustainable Development Goals @ Drexel
Abstract
Purpose of Review This review examines Electronic Nicotine Delivery Systems (ENDS) use behavior during pregnancy, including the prevalence of and transitions in use during pregnancy. Recent Findings Twenty-two papers addressed the prevalence of and/or transitions in ENDS use during pregnancy. Findings show a complex landscape of ENDS use. A minority (0.4-7.0%) of pregnant persons use ENDS; most commonly this occurs in the form of dual use (ENDS and combustible cigarettes (CC); 75%). Many pregnant persons report using ENDS because they perceive them to be a lower-risk alternative and/or potential cessation aide for CC smoking. However, while a subset of those who use ENDS do quit all tobacco product use during pregnancy, only a small proportion switch from exclusive CC smoking to exclusive ENDS use. ENDS are a somewhat new addition to the tobacco product landscape. The perception of ENDS as a lower-risk alternative may contribute to ENDS use in pregnancy. There is insufficient evidence to support the notion that ENDS facilitates the cessation of tobacco product use during pregnancy.
Metrics
Details
- Title
- Electronic Nicotine Delivery Systems (ENDS) Use and Pregnancy I: ENDS Use Behavior During Pregnancy
- Creators
- Elise E. DeVito - Yale UniversityTessa Fagle - Yale UniversityAlicia M. Allen - University of ArizonaRaina D. Pang - Keck Hospital of USCNicole Petersen - Neurobehavioral SystemsPhilip H. Smith - Miami UniversityAndrea H. Weinberger - Yeshiva University
- Publication Details
- Current addiction reports, v 8(3), pp 347-365
- Publisher
- Springer Nature
- Number of pages
- 19
- Grant note
- Eunice Kennedy Shriver National Institute on Child Health and Development (NICHD) R01DA046360; R01HD100418; K01DA040043; R00DA045749 / National Institute on Drug Abuse (NIDA); United States Department of Health & Human Services; National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA) FDA Center for Tobacco Products (CTP); United States Department of Health & Human Services
- Resource Type
- Journal article
- Language
- English
- Academic Unit
- A.J. Drexel Autism Institute
- Web of Science ID
- WOS:000674397700001
- Scopus ID
- 2-s2.0-85110647094
- Other Identifier
- 991022030930104721
UN Sustainable Development Goals (SDGs)
This publication has contributed to the advancement of the following goals:
InCites Highlights
Data related to this publication, from InCites Benchmarking & Analytics tool:
- Collaboration types
- Domestic collaboration
- Web of Science research areas
- Psychiatry
- Substance Abuse